Benitec Biopharma Inc. (BNTC) › Cash & EquivalentsBenitec Biopharma Inc. (BNTC) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $11.88M2019: $15.72M2020: $9.80M2021: $19.77M2022: $4.06M2023: $2.48M2024: $50.87M2025: $97.74M$97.74M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$97.74M+92.2%2024$50.87M+1953.5%2023$2.48M-39.0%2022$4.06M-79.5%2021$19.77M+101.7%2020$9.80M-37.6%2019$15.72M+32.3%2018$11.88M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share